Pilot outcomes research: effects and costs of bortezomib in relapsed or refractory multiple myeloma

Margreet Franken; JG (Jennifer G.) Gaultney; Hedwig Blommestein; Siok Swan Tan; Chantal van Gils; PC Huijgens; Pieter Sonneveld; Ken Redekop; Carin Uyl - de Groot

Pilot outcomes research: effects and costs of bortezomib in relapsed or refractory multiple myeloma

Margreet Franken, JG (Jennifer G.) Gaultney, Hedwig Blommestein, Siok Swan Tan, Chantal van Gils, PC Huijgens, Pieter Sonneveld, Ken Redekop, Carin Uyl - de Groot

Research output: Book/Report/Inaugural speech/Farewell speech › Report › Academic

6 Downloads (Pure)

Original language	English
Place of Publication	Rotterdam
Number of pages	382
Publication status	Published - 2012

Research programs

EMC NIHES-05-63-02 Quality

Access to Document

Metis_181836.pdfFinal published version, 5.43 MB

http://hdl.handle.net/1765/38245

Cite this

@book{0ae181e979744c0fab75777e218a30ba,

title = "Pilot outcomes research: effects and costs of bortezomib in relapsed or refractory multiple myeloma",

author = "Margreet Franken and Gaultney, {JG (Jennifer G.)} and Hedwig Blommestein and Tan, {Siok Swan} and {van Gils}, Chantal and PC Huijgens and Pieter Sonneveld and Ken Redekop and {Uyl - de Groot}, Carin",

year = "2012",

language = "English",

}

TY - BOOK

T1 - Pilot outcomes research: effects and costs of bortezomib in relapsed or refractory multiple myeloma

AU - Franken, Margreet

AU - Gaultney, JG (Jennifer G.)

AU - Blommestein, Hedwig

AU - Tan, Siok Swan

AU - van Gils, Chantal

AU - Huijgens, PC

AU - Sonneveld, Pieter

AU - Redekop, Ken

AU - Uyl - de Groot, Carin

PY - 2012

Y1 - 2012

M3 - Report

BT - Pilot outcomes research: effects and costs of bortezomib in relapsed or refractory multiple myeloma

CY - Rotterdam

ER -